Constantine Davides
Stock Analyst at Citizens
(1.01)
# 3,908
Out of 5,147 analysts
120
Total ratings
29.73%
Success rate
-22.28%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMN AMN Healthcare Services | Maintains: Market Outperform | $22 → $24 | $19.48 | +23.20% | 14 | Feb 23, 2026 | |
| PGNY Progyny | Upgrades: Market Outperform | $30 | $17.69 | +69.59% | 4 | Jan 20, 2026 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $36 → $38 | $32.46 | +17.07% | 8 | Jan 13, 2026 | |
| EVH Evolent Health | Maintains: Market Outperform | $11 → $10 | $3.25 | +207.69% | 12 | Jan 6, 2026 | |
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $76.49 | +59.50% | 6 | Dec 4, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $23.75 | +30.53% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $7.58 | +216.62% | 11 | Nov 7, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $25.65 | +87.13% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $103.53 | +44.89% | 4 | Jul 16, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $12.23 | - | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $7.08 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.59 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $82.96 | +36.21% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $31.73 | -18.06% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $191.86 | +29.26% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $21.23 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $8.70 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.05 | +400.00% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.54 | +22,988.29% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $23.70 | -36.71% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $22.96 | -2.00% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $2.45 | +246.94% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.01 | +1,286.14% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.54 | +66,492.67% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.15 | +281,150.00% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.88 | +4,437.21% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.21 | +2,716.90% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.38 | +57,871.01% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $597,600 → $298,800 | $4.14 | +7,217,291.30% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.25 | +33,900.00% | 2 | Sep 23, 2022 |
AMN Healthcare Services
Feb 23, 2026
Maintains: Market Outperform
Price Target: $22 → $24
Current: $19.48
Upside: +23.20%
Progyny
Jan 20, 2026
Upgrades: Market Outperform
Price Target: $30
Current: $17.69
Upside: +69.59%
Option Care Health
Jan 13, 2026
Reiterates: Market Outperform
Price Target: $36 → $38
Current: $32.46
Upside: +17.07%
Evolent Health
Jan 6, 2026
Maintains: Market Outperform
Price Target: $11 → $10
Current: $3.25
Upside: +207.69%
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $76.49
Upside: +59.50%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $23.75
Upside: +30.53%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $7.58
Upside: +216.62%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $25.65
Upside: +87.13%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $103.53
Upside: +44.89%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $12.23
Upside: -
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $7.08
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.59
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $82.96
Upside: +36.21%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $31.73
Upside: -18.06%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $191.86
Upside: +29.26%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $21.23
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $8.70
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.05
Upside: +400.00%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.54
Upside: +22,988.29%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $23.70
Upside: -36.71%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $22.96
Upside: -2.00%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $2.45
Upside: +246.94%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.01
Upside: +1,286.14%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $0.54
Upside: +66,492.67%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.15
Upside: +281,150.00%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.88
Upside: +4,437.21%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.21
Upside: +2,716.90%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.38
Upside: +57,871.01%
Sep 28, 2022
Maintains: Buy
Price Target: $597,600 → $298,800
Current: $4.14
Upside: +7,217,291.30%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.25
Upside: +33,900.00%